Navigation Links
Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results

ompetition, and others stated in risk factors contained in our SEC filings.  We cannot assure that we have identified all risks or that others may emerge which we do not anticipate.  You should not place undue reliance on forward-looking statements.  Although subsequent events may cause our views to change, we disclaim any obligation to update forward-looking statements.

Galectin Therapeutics and its associated logo is a trademark of Galectin Therapeutics Inc.

 Condensed Consolidated Statements of OperationsThree Months
EndedDecember 31,Twelve MonthsEndedDecember 31,2012201120122011(in thousands, except per share data)

(unaudited)Operating expenses:  Research and development




$3,552  General and administrative




6,857  Total operating expenses




10,409Total operating loss




(10,409)Other income and (expense):  Interest income




18  Change in fair value of warrant liabilities




(524)  Other income




-Total other income (expense)




(506)Net loss




$(10,915)Preferred stock dividends and accretion costs




(1,798)Net loss applicable to common stock




$(12,713)Basic and diluted net loss per share

$  (0.17)

$  (0.29)

$  (0.72)

$  (1.06)Shares used in computing basic and diluted net loss per share




11,986 Condensed Consolidated Balance She

SOURCE Galectin Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Galectin-3 Assessed as a Biomarker of Heart Failure: Key Clinical Trial Findings Published by Dove Medical Press
2. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
3. Nile Therapeutics Reports 2011 Third Quarter Financial Results
4. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
5. Fate Therapeutics Strengthens Its iPSC Platform
6. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
7. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
8. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
9. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
10. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
11. Aratana Therapeutics Completes $15 Million Series B Financing
Post Your Comments:
(Date:10/8/2015)... 2015 Global Biologics and ... and Biosimilars industry . --> Big ... Biosimilars Industry 2015 Deep Market Research Report, Size, ... professional and depth research report on Global ... ) , --> ) , ...
(Date:10/8/2015)...  The ALS Association, in partnership with Prize4Life, is ... revolutionize communication technology solutions for people living with ALS. ... (amyotrophic lateral sclerosis) is a progressive neurodegenerative disease that ... spinal cord. Eventually, people with ALS lose the ability ... to total paralysis and death within two to five ...
(Date:10/8/2015)... 2015  Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... within its Applied Diagnostics and Testing business segment ... product line with ten certified Snap-N-Spike ® ... and their stable-labeled internal standards. These new solution ... taurocholic acid and native and deuterium-labeled analogs of ...
(Date:10/8/2015)... (PRWEB) , ... October 08, 2015 , ... ... in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results in dysfunction ... and sticky mucus accumulates in the lungs. This mucus is very difficult to ...
Breaking Biology Technology:
... July 18 - Exhibition Opens at The ... Tickets to the next blockbuster exhibition to premiere ... from physician, scientist and anatomist Dr.,Gunther von Hagens, go ... (Photo: ), In partnership ...
... National Stem,Cell Holding, Inc. (OTC: NHGI) today ... exhibiting at the 16th Annual International,World Congress on ... July,17 -- 19, 2008. Dr. Kenneth Steiner, MD, ... panelist. Dr. Steiner will introduce the company,s first,commercial ...
... Using Ion Channel Targets for ... August 6th at 10:10, CLEVELAND, July 17 ... cell lines and services for,drug-discovery and development applications will ... next month. The Cleveland-based,company will be exhibiting in booth ...
Cached Biology Technology:
(Date:9/8/2015)... BOSTON , Sept. 8, 2015  Affectiva, ... of Emotion as a Service, a new data ... Based on Affectiva,s highly accurate and ... and analytics capabilities, slated to transform industries such ... app development, retail, customer experience, online education, HR, ...
(Date:9/2/2015)... 2, 2015 Security of data and ... banks, government organizations, telecommunications, hospitals, as well as ... previously being used to prevent unauthorised access. Technological ... wherein individuals could gain access to secure premises ... as hardware devices and numeric codes. However, hackers ...
(Date:9/1/2015)... 1, 2015  Automation and pre-processing are reducing ... screening. This is the first step toward a ... become unintrusive. An assortment of portal scanners, biometric ... investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
Breaking Biology News(10 mins):
... have an enormous carbon footprint, but often energy is ... comfortable temperature. Research to be published in the ... shows how the ubiquity of smart phones connected to ... and reduce heating or air conditioning for unused spaces. ...
... "robust" jaw and skull bones was a muscular creature with ... than previously thought, scientists have discovered., Researchers found a partial ... dated to 1.34 million years old and belonging to ... site in Tanzania. The find, published in the latest edition ...
... widespread fascination with sharks, the world,s oldest ocean predators have ... a great white shark,s genetic code has fished up big ... since before dinosaurs roamed. Cornell researchers have discovered that ... an array of different functions including metabolism match ...
Cached Biology News:
Parathyroid Hormone Receptor 2 [PTHR2]...
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
Biology Products: